Diabetes and the Mediterranean diet: A beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity

QJM: An International Journal of Medicine

Volumn 93, Issue 2, 2000, Pages 85-91

  Ryan, M ^a   Mcinerney, D ^a   Owens, D ^b   Collins, P ^c   Johnson, A ^c   Tomkin, G H ^a,b,d  

^a Adelaide Meath Hospital   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LINOLEIC ACID; MEMBRANE LIPID; OLEIC ACID; SULFONYLUREA;

ADIPOCYTE; ADIPOCYTE MEMBRANE; ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMORAL ARTERY; GAS LIQUID CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SOUTHERN EUROPE;

EID: 0033974996     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/93.2.85     Document Type: Article

References (33)

1. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR. Impaired endothelium-dependent and independent vasodilatation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:771-6.
2. Enderle M-D, Benda N, Schmuelling R-M, Haering HU, Pfohl M. Preserved endothelial function in IDDM patients, but not in NIDDM patients compared with healthy subjects. Diabetes Care 1998; 21:271-6.
3. Galle J, Schneider R, Winner B, Lehmann-Bodem C, Schinzel R, Munch G, Conzelmann E, Wanner C. Glycoxidised LDL impair endothelial function more potently than oxidised LDL: role of enhanced oxidative stress. Atherosclerosis 1998; 138:65-77.
4. Stroes ESG, Koomans HA, deBruin TWA, Rahelink TJ. Vascular function in forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346:467-71.
5. Serne EH, Stehouwer C, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker A, Gans RO. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99:896-902.
6. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 2601-10.
7. Tack CJJ, Ong MKE, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998; 41:569-76.
8. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetologica 1996; 33:205-10.
9. Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH. The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes. Diabetic Medicine 1997; 14:1051-8.
10. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106:83-97.
11. Tkac I, Kimball BP, Lewis G, Uffelman K, Steiner G. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler Thromb Vasc Biol 1997; 17:3633-8.
12. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, Nakano T, Nakayima K, Yasue H. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 1998; 137:341-9.
13. Ryan M, Maddigan C, Owens D, Johnson A, Collins P, Tomkin GH. Effect of diet on post-prandial lipoprotein composition in non-insulin-dependent diabetes. Diabetic Med 1998; 15:S42.
14. Rodriguez JC, Gil-Gomez G, Hegardt G, Haro D. Peroxosome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 1994; 269:18767-72.
15. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J. Induction of acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by peroxisome proliferator response element in C promoter. J Biol Chem 1995; 18:19269-76.
16. Schwartz S, Raskin P, Fonseca V, Graveline JF. Troglitazone and Exogenous Insulin Study Group. Effect of Troglitozone in insulin-treated patients with type 2 diabetes mellitus. N Engl J Med 1998; 338:861-6.
17. Tong P, Thomas T, Berrish T, Humphriss D, Barrioconal L, Stewart M, Walker M, Wilkinson R, Alberti KGMM. Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet 1995; 345:357-8.
18. Philips DIW, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the OGTT with specific measurements of insulin resistance and insulin secretion. Diabetic Med 1994; 11:286-92.
19. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non invasive detection of endothelial dysfunction in children and adults at risk of atheroslerosis. Lancet 1992; 340:1111-15.
20. Rodbell M. Metabolism of isolated fat cells. 1 Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239:375-80.
21. Garvey WT, Olefsky JM, Mattheai S, Marshall S. Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 1987; 262:189-97.
22. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipocyte cell. J Biol Chem 1980; 255:4758-62.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509.
24. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH. Oxidation of low density lipoprotein in non-insulin dependent diabetes: Its relationship to fatty acid composition. Diabetologia 1995; 38:1300-6.
25. Low CC, Grossman EB, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 1996; 45:569-75.
26. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH. Lipoprotein composition in NIDDM. The effect of dietary oleic acid on composition and oxidisability and function of low and high density lipoproteins. Diabetologia 1996; 39:667-76.
27. Garg A. High monounsaturated fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998; 67(suppl):577S-82S.
28. Stein DT, Stevenson BE, Chesler MW, Basit M, Daniels MB, Turley SD, McGarry JD. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997; 100:398-403.
29. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effect of free fatty acids on glucose transport and IRS-1-associated phosphatidylinosital 3-kinase activity. J Clin Invest 1999; 103:253-9.
30. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Littell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994; 43:1353-7.
31. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwartzacher S, Glogar D, Bauer P, Weidinger F. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129:111-18.
32. Nagy L, Tontonez P, Alvarez JG, Chen H, Evans RY. Oxidised LDL regulates macrophage gene expression through ligand activation of PPARg. Cell 1998; 93:229-40.
33. Watts GF, Playford DA. Dyslipoprotinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998; 141:17-30.